ARRAY BIOPHARMA
Array BioPharma is a biopharmaceutical company that focuses on the development and commercialization of small molecule drugs to treat patients afflicted with cancer and other high-burden diseases. The company partnered drugs are binimetinib (MEK162), encorafenib (LGX818), selumetinib (partnered with AstraZeneca), danoprevir (partnered with Roche), ipatasertib (partnered with Genentech), larotrectinib (partnered with Loxo Oncology), and tucatinib (partnered with Cascadian Therapeutics). The company is committed to providing therapies to patients. Array BioPharma was founded on 1998 and is headquartered in Boulder, Colorado.
ARRAY BIOPHARMA
Industry:
Biotechnology Health Care Medical Pharmaceutical Therapeutics
Founded:
1998-01-01
Address:
Boulder, Colorado, United States
Country:
United States
Website Url:
http://www.arraybiopharma.com
Total Employee:
101+
Status:
Closed
Contact:
303.381.6600
Email Addresses:
[email protected]
Total Funding:
412.1 M USD
Technology used in webpage:
Domain Not Resolving Google Maps IPv6 Google Maps API Microsoft IIS 7 Oracle Cloud ASP.NET 2.0
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Redmile Group
Redmile Group investment in Post-IPO Equity - Array BioPharma
Deerfield
Deerfield investment in Post-IPO Debt - Array BioPharma
Deerfield
Deerfield investment in Post-IPO Debt - Array BioPharma
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Venture Round - Array BioPharma
Official Site Inspections
http://www.arraybiopharma.com
- Host name: 192.29.61.237
- IP address: 192.29.61.237
- Location: Zurich Switzerland
- Latitude: 47.4049
- Longitude: 8.4631
- Timezone: Europe/Zurich
- Postal: 8102
More informations about "Array BioPharma"
Array BioPharma - Crunchbase Company Profile & Funding
Array BioPharma is a biopharmaceutical company focused on the development and commercialization of targeted small molecule drugs.See details»
Array BioPharma Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Array BioPharma Inc. of Boulder, CO. Get the latest business insights from Dun & Bradstreet.See details»
Array BioPharma Inc. - LinkedIn
Array BioPharma Inc. (NASDAQ: ARRY) is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat …See details»
Array BioPharma 2025 Company Profile: Valuation, …
Information on acquisition, funding, cap tables, investors, and executives for Array BioPharma. Use the PitchBook Platform to explore the full profile.See details»
Array BioPharma Company Profile - Office Locations, Competitors …
Array BioPharma $173.77 m in annual revenue in FY 2018. See insights on Array BioPharma including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
Array BioPharma - Company Profile - Tracxn
Feb 27, 2025 Array BioPharma - Speciality biopharma company focussed on developing small molecule drugs for treatment of cancer. Acquired by Pfizer. Raised funding over 1 round from …See details»
Array BioPharma, Inc. - Drug pipelines, Patents, Clinical trials
Array BioPharma is a biopharmaceutical corporation that specializes in discovering, developing, and commercializing targeted small molecule drugs to treat patients with cancer and other …See details»
Array BioPharma Inc. - VentureRadar
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. …See details»
Organization | Array BioPharma - Purdue University
Array BioPharma Report issue Contributed to NME For profit Phase 1 Phase 2 Phase 3 Founded: Boulder CO United States (1998) Status: Acquired by Pfizer (2019) Organization Overview …See details»
Array BioPharma - Ownership and Business Overview | Mergr
Jun 17, 2019 Array BioPharma, Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted small molecule drugs to treat patients afflicted …See details»
Array Biopharma - Polyomics.org
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat debilitating and life …See details»
Pfizer Completes Acquisition of Array Biopharma
Jul 30, 2019 Pfizer Inc. (NYSE:PFE) today announced the successful completion of its acquisition of Array BioPharma Inc., advancing breakthrough science for the discovery, …See details»
Array Biopharma - Products, Competitors, Financials, Employees ...
About Array Biopharma Array BioPharma operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of targeted small molecule drugs to …See details»
Array BioPharma Inc - Company Profile and News - Bloomberg …
Company profile page for Array BioPharma Inc including stock price, company news, executives, board members, and contact informationSee details»
Array BioPharma - Contacts, Employees, Board Members
Array BioPharma is a biopharmaceutical company focused on the development and commercialization of targeted small molecule drugs.See details»
EXECUTIVE INTERVIEW - Array BioPharma: Steadily Moving to Late …
Executive Summary: Ron Squarer, Chief Executive Officer of Array BioPharma, talks about the company’s pipeline and evolution into a fully integrated, commercial-stage biopharmaceutical …See details»
Array Biopharma - Genomics.org
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat debilitating and life …See details»
Pfizer completes acquisition of Array Biopharma
Pfizer Inc. (NYSE:PFE) today announced the successful completion of its acquisition of Array BioPharma Inc., advancing breakthrough science for the discovery, development and …See details»
Alliance for Genomic Discovery completes 250,000 whole …
2 days ago Illumina and NashBio announce that the Alliance for Genomic Discovery – a consortium of biotech and biopharma organizations – has completed its initial goal of …See details»
The most innovative companies in artificial intelligence for 2025
3 days ago Why Nvidia, OpenAI, Google DeepMind, Anthropic, and Microsoft are among Fast Company’s Most Innovative Companies for 2025.See details»